SCHEMBL1724899

SCHEMBL1724899

O=C(O)NC1CN(Cc2ccccc2)CC1c1cc(F)c(F)cc1F

nearest known ligand 0.48

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 3/20 0.48
SIGMAR1 Q99720 11/20 0.47
L3MBTL1 Q9Y468 1/20 0.45
GRIN2B Q13224 1/20 0.42
SLC6A12 P48065 1/20 0.42
TMEM97 Q5BJF2 1/20 0.42
MCHR1 Q99705 1/20 0.42
POLB P06746 1/20 0.42
DRD2 P14416 1/20 0.42
DRD4 P21917 1/20 0.42
DRD3 P35462 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5924067 1.00 DPP4 (0.48) DPP4SIGMAR1L3MBTL1GRIN2BSLC6A12
SCHEMBL1240975 0.91 SIGMAR1 (0.51) DPP4SIGMAR1L3MBTL1SLC6A12TMEM97
SCHEMBL5123894 0.91 SIGMAR1 (0.51) DPP4SIGMAR1L3MBTL1SLC6A12TMEM97
SCHEMBL470519 0.86 DPP4 (0.48) DPP4SIGMAR1GRIN2BDRD2DRD3
SCHEMBL147898 0.85 L3MBTL1 (0.46) DPP4SIGMAR1L3MBTL1DRD2DRD4
SCHEMBL147897 0.85 L3MBTL1 (0.46) DPP4SIGMAR1L3MBTL1DRD2DRD4
SCHEMBL147896 0.85 L3MBTL1 (0.46) DPP4SIGMAR1L3MBTL1DRD2DRD4
SCHEMBL2934745 0.82 DPP4 (0.67) DPP4KMT2A
SCHEMBL2934740 0.82 DPP4 (0.67) DPP4KMT2A
SCHEMBL2934742 0.82 DPP4 (0.67) DPP4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406251-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS Prosidion Limited (GB) 2012-01-18 EP disclosed
WO-2010103334-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2010-09-16 WO disclosed